Skip to main content
. 2017 Oct;9(10):3919–3926. doi: 10.21037/jtd.2017.09.79

Table 2. Comparison of clinicopathologic features among patients harboring different genes.

Variables ALK ROS1 Wild type P (ALK vs. wild) P (ROS1 vs. wild)
Gender 0.19 0.39
   Male 42 15 334
   Female 47 17 277
Age at diagnosis (years) 0.08 0.65
   <60 58 19 338
   ≥60 31 13 273
Smoking history <0.001 0.0002
   Yes 19 5 299
   No 70 27 312
Histology 0.006 0.015
   Solid predominant 18 8 66
   Non-solid predominant 56 20 460
Stage at diagnosis 0.14 0.55
   I–IIIA 67 20 413
   IIIB/IV 22 12 198
TTF1 0.01 0.035
   Positive 70 26 413
   Negative 5 0 90
Napsin A 0.04 0.25
   Positive 76 28 443
   Negative 2 0 52
P63 0.32 0.57
   Positive 1 0 24
   Negative 64 21 435
CK5/6 0.39 0.40
   Positive 2 0 29
   Negative 72 26 462